Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FK-1706 shows promise in painful diabetic neuropathy

Jan. 14, 2009

Mechanism behind leptin resistance clarified, possible treatments tested in vivo

Jan. 14, 2009

Clinical investigation of Diasome's hepatic-directed vesicle-insulin advances

Jan. 14, 2009

Ardea presents positive results from phase I RDEA-594 study

Jan. 14, 2009

Genzyme and Isis commence several mipomersen trials

Jan. 14, 2009

Galapagos and Merck & Co. enter global strategic alliance in obesity and diabetes

Jan. 13, 2009

Altus reports results from completed phase Ic study of ALTU-238

Jan. 13, 2009

First phase III Contrave trial meets co-primary and key secondary endpoints

Jan. 13, 2009

New GHS-R1a ligands claimed by GSK as a treatment option for obesity

Jan. 13, 2009

GSK divulges a series of ghrelin receptor ligands for the treatment of binge eating

Jan. 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...